Different medical institutions have selected different imported and domestic brand instruments: 38 domestic and 58 imported.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

2020 has been a magical year for the in vitro diagnostic industry. How will history record the year 2020?

Find out what is going on in Chinese in vitro diagnostic industry.

Vazyme's IPO was Accepted, Planning to Raise 1.225 Billion Yuan; Amoy Diagnostics, Merck KGaA Partner for Lung Cancer Companion Diagnostic Development in China.

Another Capital Raising Boom in in vitro diagnostic industry.

In recent years, because of the optimistic attitude about the development of IVD industry, various VC and PE investments are very active.

On December 19, at the 16th International Respiratory Symposium in Changshu, Abbott announced that it had joined the International Smart Health Alliance and signed an important strategic cooperation with the China Lung Cancer Prevention Alli

On December 18, 2020, Hipro biotechnology Corp announced the completion of the c-round financing of over 100 million YUAN.

CSRC has approved the registration of the initial public offering of Jiangsu HOB Biotech (HOB) Co., Ltd. on the science and technology innovation board.

Recently, TÜV SÜD Product Service GmbH an EU Notified Body certified the first IVDR CE certificate in the field of chemiluminescence in China, and its winner is Shenzhen New Industries Biomedical Engineering Co., Ltd.

View this email in Your Browse Official Website Click for more Timetable of CACLP CISCE 2021 will be continuously updated. Read More The 8th China IVD Industry Development Conference The 8th China IVD Industry Development Conference is sche